The induction of proteolysis by expression of the influenza virus PA polymerase subunit is the only biochemical activity ascribed to this protein. In the course of studying viral protein synthesis by twodimensional gel electrophoresis, we observed the existence of several PA isoforms with different isoelectric points. These isoforms were also present when the PA gene was singly expressed in three different expression systems, indicating that a cellular activity is responsible for its post-translational modification. In vivo labelling with [ 32 P]orthophosphate, followed by two-dimensional gel electrophoresis, clearly demonstrated the incorporation of phosphate into the PA molecule. Phosphoserine
Introduction
Replication and transcription of the influenza virus genome are carried out by ribonucleoprotein complexes that contain viral RNA associated with four viral proteins, the nucleoprotein (NP) and the three subunits of the polymerase (PB1, PB2 and PA) (Krug, 1989) . These polymerase subunits are responsible for the synthesis of the three classes of viral RNA molecules : (i) mRNAs that are capped and polyadenylated ; (ii) virion RNAs found in the viral particle (vRNA) ; and (iii) cRNAs that serve as templates for the synthesis of vRNA (Krug, 1989 ; Mahy, 1983) . Different studies have characterized some of the roles of each subunit in the polymerase complex. It has been shown that the PB1 subunit is involved in the elongation of the growing mRNA chain (Braam et al., 1983) . It contains motifs typical of an RNA-dependent RNA polymerase (Poch et al., 1990) that are essential for its biological activity (Biswas & Nayak, 1994) . The PB2 subunit has been shown to interact with cap 1 structures (Blaas et al., 1982 ; Ulmanen et al., 1981) , and its possible involvement in the endonucleolytic cleavage of the host cellular mRNA precursors has been reported (Hagen et al., 1994 ; Licheng et al., 1995) . The experiments carried out with ts virus mutants with defects in the PA gene have shown that, under these conditions, there is a defect in viral RNA replication but not in viral transcription (Mahy, 1983) , although the mechanism for this is not known. We have found that when PA is expressed from cDNA, it induces a generalized proteolysis of viral and cellular co-expressed proteins (Sanz-Ezquerro et al., 1995) . The amino-terminal third of the molecule is necessary and sufficient to induce this proteolysis and there is a correlation between nuclear localization of the protein and induction of proteolysis, suggesting that nuclear transport of PA could be required to bring about this activity (Sanz-Ezquerro et al., 1996) . The relationship of this PA biological activity and its presumptive role in RNA replication is uncertain at present. When studying the possible contribution of this proteolysis to the shutoff of cellular protein synthesis produced by influenza virus infection, we carried out two-dimensional gel electrophoresis of proteins from influenza virus-infected cells and demonstrated the presence of different PA isoforms. In this report, we show that PA protein can be labelled in vivo with [$#P]orthophosphate, contains phosphorylated serine and threonine residues and is a substrate for casein kinase II (CKII) in vitro.
Methods
Cells, viruses and plasmids. The COS-1 cell line (Gluzman, 1981) was obtained from Y. Gluzman and the MDCK cell line was purchased from ATCC. Cell cultures were grown in Dulbecco's modified Eagle medium (DMEM) containing 5 % foetal bovine serum (FBS). The influenza virus strain A\Victoria\3\75 was grown in MDCK cells as reported previously (Ortı! n et al., 1980) . Vaccinia virus (VV) VT7 (originally known as vTF7-3) is a recombinant virus that expresses phage T7 RNA polymerase (Fuerst et al., 1987) and was kindly provided by B. Moss (NIH, Bethesda, MD, USA).
The genes for PB1, PB2 and PA were cloned into expression vector pTM1 (Fuerst et al., 1987) so that the ATG of each gene became part of the unique NcoI site of the plasmid. This was achieved by engineering the 5h region of each open reading frame by PCR to create an NcoI site at the ATG of each gene, sequencing the PCR product and then adding the remaining part of the influenza virus gene using the closest convenient restriction site. The assembled genes were then transferred into plasmid pTM1. Derivatives of pTM1 containing the three influenza virus polymerase genes were each used to transfer the influenza virus genes into the thymidine kinase gene locus of VV. Using this method, VV recombinant viruses VPB1, VPB2 and VPA, which are capable of expressing high levels of PB1, PB2 or PA proteins by dual infection with VT7 virus, were obtained. The simian virus 40 (SV40) recombinant virus SVPA, which expresses the influenza virus polymerase PA subunit of strain A\Victoria\3\75, has been described elsewhere (de la Luna et al., 1993 ; Nieto et al., 1992) . The pGEM3 recombinant plasmid encoding the influenza virus PA polymerase subunit (pGPA) has been previously described (Mena et al., 1994) .
Infection and transfection.
Infection of COS-1 cells with influenza virus or SVPA recombinant virus was done with 10 and 1-5 p.f.u. per cell, respectively. Subconfluent monolayers of COS-1 cells were infected with VT7 virus at 5-10 p.f.u. per cell. After 1 h at 37 mC, cells were transfected with pGPA plasmid by the liposome-mediated method, using lipofectin reagent (Gibco BRL) according to the manufacturer's recommendations (2 µl lipofectin\µg DNA). Cells were incubated at 37 mC in serum-free DMEM for 16-20 h. For double infections, COS-1 cells were inoculated with VT7 plus VPA, VPB2 or VPB1 recombinants of each virus at 5 p.f.u. per cell in DMEM medium plus 2 % FBS. After adsorption for 1 h, the inoculum was removed and the cultures were incubated for 24 h.
Western blotting. Total cell extracts were used for Western blot assays. The extracts were resuspended in sample loading buffer and the proteins were resolved by electrophoresis in SDS-polyacrylamide gels. Gels were then transferred to Immobilon membranes (Millipore) as described previously (Towbin et al., 1979) . After blocking with 3 % BSA in PBS for 1 h at room temperature, the filters were incubated for 1 h at room temperature with the primary antibody diluted in PBS buffer containing 0n25 % Tween-20 and 0n1 % BSA. The filters were washed in PBS plus 0n25 % Tween-20 for 1 h with four changes and incubated for 1 h at room temperature with peroxidase-conjugated secondary antibodies (goat anti-mouse peroxidase or protein-A peroxidase, 1\6000 dilution ; Bio-Rad). Finally, the filters were washed in PBS plus 0n25 % Tween-20 for 1 h with four changes and the specific bands were visualized by enhanced chemiluminescence (Amersham). The following antibodies were used : for PA protein, a mixture of monoclonal antibodies 9, 11, 12 and 14 made against E. coli-expressed PA (1\40 dilution of each from culture supernatant) (Ba! rcena et al., 1994) ; for PB2 protein, PARB2 8N, a rabbit antiserum that was prepared by immunizing animals with a carboxyl-terminal-truncated form of PB2 (1\100 dilution) ; and for PB1 protein, a rabbit antiserum prepared by immunization with a fusion protein containing the amino-terminal 250 amino acids (Gonzalez et al., 1996) (1\100 dilution). For detection of phosphoserine and phosphothreonine, a mixture of five different monoclonal antibodies recognizing different phosphoserine epitopes and a unique monoclonal antibody were used (1µg\ml each as working concentration), respectively (antibodies obtained from BIOMOL). Finally, phosphotyrosine detection was carried out with an anti-phosphotyrosine antibody conjugated to protein-PA peroxidase (1\1000 dilution ; UBI). Two-dimensional analysis. Cultures of COS-1 cells in 16-mmdiameter dishes were mock-infected, infected with influenza virus or SVPA recombinant, infected with VT7 virus and transfected with a plasmid expressing PA (pGPA), or infected with VT7 plus VPA at 5 p.f.u. per cell for each virus. For protein synthesis analysis, cells were starved for 90 min in methionine-and cysteine-free DMEM and labelled for 1 h with 500 µCi of a mixture of [$&S]Met-Cys (Pro-mix ; Amersham) per ml in 100 µl of the same medium. Cells were then washed to remove unincorporated label and then chased for 1 h with DMEM medium containing 5 % FBS, 2 mM methionine and 2 mM cysteine. Finally, the cells were washed with PBS and resuspended in 100 µl lysis buffer. Twodimensional gel electrophoresis was performed as described by O'Farrell (1975) with minor modifications (Santare! n & Bravo, 1987) . Briefly, the first dimension separation to resolve acidic proteins (isoelectric focusing) was carried out in 230i2n3 mm, 4 % polyacrylamide gels containing 2 % ampholytes (1n6 %, pH 5-7 ; 0n4%, pH 3n5-10) at 1200 V for 20 h. The second dimension separation was performed overnight at room temperature in 15 % polyacrylamide gels (24i24 cm). Gels were processed for fluorography (Laskey & Mills, 1975) in the case of methioninecysteine incorporation studies, dried and exposed at k70 mC for various periods of time. The fluorograms were scanned using a Molecular Dynamics computing densitometer (model 300A). Some gels were transferred to nitrocellulose membranes as reported (Towbin et al., 1979) and processed by Western blotting to detect PA protein as described above. For radioactive phosphate incorporation, COS-1 cells were infected with VT7 alone or VT7 in combination with VPA. At 18 h postinfection (p.i.), cells were starved for 90 min in phosphate-free DMEM and labelled for 2 h with 1 mCi of [$#P]orthophosphate (Amersham) per ml in the same medium. After this, cells were washed twice with PBS and resuspended in lysis buffer.
Expression and purification of CKII catalytic subunit. The α catalytic subunit of CKII was expressed and purified from E. coli BL21(DE3) harbouring plasmid pBB-3 as described (Grankowski et al., 1991) . Enzymatic activity was assayed in an incubation mixture containing 25 mM HEPES (pH 7n4), 10 mM MgCl # , 50 µM ATP, [γ-$#P]ATP (specific activity 500 c.p.m.\pmol) and using 0n2 mg\ml dephosphorylated casein as substrate. Reactions were started by the addition of 2-5 µl pure enzyme (specific activity about 50 U\mg protein) in a final volume of 20 µl. Heparin (10 µM) was used to inhibit CKII activity.
In vitro phosphorylation. COS-1 cells were infected with VT7 alone or VT7 plus VPA at 5 p.f.u. per cell for each virus for 24 h. The cells Influenza virus PA protein phosphorylation Influenza virus PA protein phosphorylation were collected in RIPA medium [150 mM NaCl, 1n0 % NP-40, 0n5% deoxycholate, 0n1 % SDS, 50 mM Tris (pH 8n0)] and sonicated three times for 20 s. Cell extracts were used for PA immunoprecipitation using specific monoclonal antibodies as previously described (Sanz-Ezquerro et al., 1995) . The immunoprecipitates were washed twice with TNE [50 mM Tris (pH 7n5), 5 mM EDTA, 0n1 M NaCl] plus 1 % NP-40, twice with RIPA and three times with TNE. Immunoprecipitates were used for in vitro phosphorylation with purified human CKII α subunit expressed in E. coli. The phosphorylation reaction was carried out in 20 mM MOPS (pH 7n0), 50 mM KCl, 10 mM MgCl # , 5 mM DTT, 50 µM GTP, 20 mM NaF, 50 µM Na $ VO % , 5 µM okadaic acid, 5 µCi [γ-$#P]GTP and 5 µl purified CKII α subunit. After 1 h at 32 mC, loading buffer was added and PA was resolved by SDS-PAGE in a 7n5 % gel. After transfer to Immobilon membranes, $#P-labelled compounds were detected by autoradiography and the same filter was processed for PA Western blotting as described.
Results

PA protein is present in several isoforms in influenza virus-infected cells
We have previously reported that influenza virus infection causes degradation of cellular RNAs (Beloso et al., 1992) and that expression of PA protein leads to a generalized proteolysis (Sanz-Ezquerro et al., 1995) . To ascertain the possible role of these phenomena in the shutoff of cellular protein synthesis, the synthesis of viral and cellular proteins by two-dimensional gel electrophoresis of extracts of pulse-labelled, influenza virus-infected COS-1 cells was examined. During these studies, the appearance of several labelled spots of identical molecular mass (about 90 kDa) and different isoelectric points, all within the acidic range, was observed after infection. Among the proteins encoded by influenza virus, the polymerase subunits are those with the highest molecular mass, ranging from 87 to 90 kDa (Lamb, 1989) . Two of the subunits (PB1 and PB2) are basic proteins whereas PA has been described as an acidic protein (Horisberger, 1980) . Therefore, we decided to analyse whether these spots represented the PA protein. Thus, COS-1 cells were mock-infected or infected with influenza virus strain A\Victoria\3\75. At 4 h (early) or 9 h (late) p.i., the cells were pulse-labelled with [$&S]Met-Cys for 1 h and chased for 1 h as described in Methods. After this time, the corresponding cell extracts were analysed by two-dimensional gel electrophoresis. Specific spots of the size and isoelectric point of PA were observed in influenza virus-infected cells but not in mockinfected cells (Fig. 1) . These spots were more apparent as the infection proceeded. To ascertain whether these spots corresponded to PA isoforms, a sample of late influenza virusinfected cells was subjected to two-dimensional separation, transferred to a nitrocellulose membrane and immunoblotted with a mixture of monoclonal antibodies specific for PA protein. The results showed a strict correlation between the spots developed with the antibodies against PA and the labelled spots (Fig. 1) , indicating the presence of PA isoforms in cells infected with influenza virus. 
Post-translational modification of PA protein is independent of other viral genes
Next, we considered whether the appearance of PA isoforms was the consequence of an activity present in or stimulated by influenza virus infection or if these isoforms could be generated independently of influenza virus infection. To distinguish between these two possibilities, the PA protein was expressed by infection of COS-1 cells with either SVPA (Nieto et al., 1992) or VT7 (Fuerst et al., 1987) and transfection with pGPA (Sanz-Ezquerro et al., 1995) . Samples of COS-1 cells expressing the PA subunit from either system were pulselabelled with [$&S]Met-Cys and chased as described above for influenza virus-infected cells and then processed for twodimensional analysis. The results are presented in Fig. 2 . At least four different protein isoforms could be observed when PA protein was expressed as a single influenza virus gene ; spatial co-ordinates were identical to those present in influenza virus-infected cells. Therefore, it can be concluded that no other influenza virus proteins are needed for the generation of PA protein isoforms. The fact that these isoforms can be observed using two expression systems as different as an SV40 virus recombinant and a T7 RNA polymerase-driven expression system, makes it very unlikely that the activity responsible for PA protein modification is encoded by the EHD J. J. Sanz-Ezquerro and others J. J. Sanz-Ezquerro and others expression vector. It seems more likely that a cellular activity is involved in the process, although at present it is uncertain whether such activity is constitutively expressed or induced by viral gene expression. In all three PA expression systems used, there was a prominent isoform that contained around 90 % of the total PA synthesized protein, as determined by scanner densitometry of the $&S-labelled proteins.
PA protein is phosphorylated in vivo
Usually, isoforms with different isoelectric points detected by two-dimensional analysis represent different phosphorylation states of the protein. Therefore, we checked whether PA protein could be phosphorylated in vivo by labelling with [$#P]orthophosphate in the incubation medium. Despite several attempts we could only weakly detect $#P-labelled PA protein from influenza virus-or SVPA-infected cells, or from VT7-infected cells that were transfected with pGPA (data not shown). This might be due to the low levels of PA in these systems and\or PA-induced proteolysis for which the PA protein itself is a substrate (Sanz-Ezquerro et al., 1995) . A shortlived phosphorylation mechanism, together with the possibility that the most abundant PA isoform is poorly phosphorylated, could be also responsible for the low level of labelled phosphate incorporated in vivo into PA in these experiments. A recombinant VV system expressing PA at higher levels was Ab-PA VT7 VT7+VPA Fig. 3 . PA protein is a phosphoprotein. COS-1 cells were infected with VT7 alone or VT7 in combination with VPA (VT7jVPA), and pulselabelled with [ 32 P]orthophosphate for 2 h. Total cell extracts were analysed by two-dimensional gel electrophoresis. The pH gradient was as described in Fig. 1 therefore selected. Cells were infected with VT7 and VPA and labelled with [$#P]orthophosphate at 20 h p.i. After 2 h, cells were collected and the extracts were processed for twodimensional analysis followed by transfer to nitrocellulose to allow the identification of phosphoproteins and immunodetection of specific PA spots. The results are presented in Fig.  3 and indicate the appearance of at least four phosphoisoforms recognized by antibodies specific for PA protein that are absent in VT7-infected cells. These results demonstrate that PA protein is phosphorylated in vivo. The fact that the same pattern of synthesized PA isoforms can be observed from influenza virus-infected cells makes a different post-translational modification in infected cells very unlikely and indicates that the protein is also phosphorylated in that system. Next, we tried to detect phosphorylated epitopes in PA protein. To do this, we used total cell extracts of COS-1 cells infected with VT7 alone or in combination with pGPA in order to immunoprecipitate PA as previously described (SanzEzquerro et al., 1995) . After this, the samples were subjected to 7n5 % SDS-PAGE, transferred to Immobilon membranes and analysed by Western blotting using monoclonal antibodies recognizing phosphoserine or phosphothreonine epitopes. The same filters were later processed for PA detection to unambiguously ascribe the presence of phosphorylated epitopes in the PA protein. The results (Fig. 4) showed the presence of both phosphoserine and phosphothreonine epitopes in the PA molecule. Positive reactivity was clearly observed for both phosphoepitopes, but the quality of the antibodies did not allow us to conclude unambiguously that the PA protein contains these phosphorylated amino acids. Then, analyses to detect the possible presence of phosphorylated tyrosine residues in the PA molecule were also done. Immunodetection studies with extracts of COS-1 cells infected with either VT7 or VT7 plus VPA were carried out ; cells infected with VT7 plus either VPB2 or VPB1 polymerase proteins were used as controls. Cellular extracts were subjected to denaturing SDS-PAGE, transferred to Immobilon membranes and immunoblotted with antibodies specific for phosphotyrosine epitopes. The same filters were later processed for PA, PB2 or PB1 immunodetection to unambiguously assign the phosphorylated epitopes to the influenza virus proteins. Although data are not available about the presence or absence of phosphoepitopes in PB1 or PB2 proteins, they were used because their high levels of accumulation would allow detection of low levels of phosphorylated amino acids and could provide stringent background levels of the anti-phosphotyrosine antibody used. As positive control, we included in the polyacrylamide gel a sample of highly purified p56 LCKglutathione transferase fusion protein (a generous gift of L. R. Borlado, Centro Nacional de Biotecnologı! a, Madrid, Spain). This is a lymphocyte-specific member of the SCR family of cytoplasmic protein-tyrosine kinases, which is phosphorylated at two tyrosine residues (Perlmutter et al., 1988) . The results are shown in Fig. 5 . Phosphorylated tyrosine residues were not apparent in any of the subunits of the influenza virus polymerase, although they were abundant (approximately 3 µg per sample) and clearly visible by staining with Coomassie brilliant blue. A positive reaction was clearly obtained with the p56 LCK purified fusion protein, although no more than 10 ng was used.
CKII phosphorylates PA protein in vitro
Our previous results indicated that the PA subunit is a phosphoprotein. The prediction of putative phosphorylation sites in the PA molecule using various criteria (Edelman et al., 1987 ; Kemp & Pearson, 1990 ) indicated the existence of four to twelve potential sites of phosphorylation by CKII, a kinase that phosphorylates its substrates at serine or threonine residues. Therefore, we studied whether PA protein could be a substrate for in vitro phosphorylation by CKII. To do this, the α catalytic subunit of human CKII was expressed and purified in E. coli BL21(DE3) strain, as described in Methods. The activity of the enzyme, when tested using casein as substrate, as well as its inhibition by heparin is shown in Fig. 6 (a) . As a source of PA protein, extracts of COS-1 cells infected with either VT7 alone or VT7 in combination with VPA recombinant virus were immunoprecipitated. Due to the high abundance of putative CKII phosphorylation sites in the amino-terminal part of the PA molecule, a monoclonal antibody that recognized the carboxy-terminal end of PA (Ab-PA 2) (Ba! rcena et al., 1994) , was used for the immunoprecipitation in order to maintain these putative aminoterminal phosphorylation sites accessible to the kinase. The immunoprecipitates were phosphorylated in vitro, as described in Methods, with purified CKII α subunit in the absence or presence of heparin, a specific inhibitor of this kinase, resolved by SDS-PAGE and transferred to Immobilon membranes. After detection of the labelled bands, the same membranes were immunoblotted using a mixture of monoclonal antibodies specific for PA (Fig. 6 b) . The results obtained clearly show the appearance of a specific labelled band (arrow in Fig. 6 b) , only present in extracts of VPA-infected cells, that disappears when Upper panels : total cell extracts were run in SDS-polyacrylamide gels, transferred to Immobilon membranes and blotted with phosphotyrosine antibody (Ab-PTyr). As a positive control, a sample of purified p56
LCK protein was included (p56 LCK) Bottom panels : the same filters were used to detect PA, PB2 or PB1 proteins, using antibodies specific for each polymerase subunit (Ab-Pol). Membranes containing extracts from VT7-infected cells or purified p56
LCK protein were blotted with anti-PA specific antibodies. heparin is added to the incubation mixture and is recognized by anti-PA monoclonal antibodies, indicating that purified human CKII can phosphorylate the PA subunit of influenza virus polymerase in vitro.
Discussion
Some influenza virus proteins undergo post-translational modification by phosphorylation, such as nucleoprotein (Almond & Felsenreich, 1982 ; Kistner et al., 1985) , nonstructural protein-1 (NS1) (Privalsky & Penhoet, 1978 , 1981 , non-structural protein-2 (NS2) (Richardson & Akkina, 1991) and the M1 protein of the WSN strain (Gregoriades et al., 1984) . Some of these modified viral proteins contain phosphoserine or phosphothreonine amino acids. Thus, phosphoserine has been found in the nucleoprotein (Privalsky & Penhoet, 1981) and the main modification site has been mapped to the serine at position 3 in the molecule (Arrese & Portela, 1996) , whereas NS1 is exclusively phosphorylated at threonine residues (Privalsky & Penhoet, 1981 (Gregoriades et al., 1984) and no data concerning the type of the modified residue(s) in NS2 are available. Considering the absence of phosphotyrosine epitopes in PA protein, its capacity to be phosphorylated in vitro by CKII and the positive reactivity with antibodies directed against phosphoserine and phosphothreonine epitopes, it seems that PA phosphorylation occurs at serine residues, threonine residues or both. Likewise, it is probable that a cellular protein kinase is involved in the post-translational modification of PA, since the pattern of isoforms of this subunit is identical when the molecule is expressed individually and when it is expressed during influenza virus infection. In agreement with these results, a protein kinase activity that resembles CKII has been described in association with purified influenza virus (Tucker et al., 1990) .
No correlation between the degree of phosphorylation of these phosphoproteins and biological function has been found. Nevertheless some interesting data concerning intracellular location and phosphorylation state are available. NS1 can be phosphorylated at two threonine residues and the modification probably takes place only within the nucleus, because with very short-pulse labelling experiments, when the protein is still located in the cytoplasm of the infected cell, no phosphorylated NS1 can be detected (Privalsky & Penhoet, 1981) . With regard to M1 protein, a mutant with a phenotype of hyperphosphorylation is aberrantly retained in the nucleus (Whittaker et al., 1995) . Treatment of influenza virus-infected cells with the general protein kinase inhibitor H7 causes a specific interference with the transport of late viral mRNAs, but not early mRNAs, from the nucleus to the cytoplasm (Vogel et al., 1994) . The inhibitor treatment also gives rise to a specific inhibition of the synthesis of influenza virus late proteins (Vogel et al., 1994) .
Since several lines of evidence indicate a functional association between M1 protein and NP, it has been speculated that this association might be regulated by phosphorylation (Arrese & Portela, 1996) . Recently, association of NS1 with influenza virus ribonucleoproteins has been found (Mario! n, 1997). Having in mind that at least four of the different proteins that are involved in the formation of influenza virus ribonucleoprotein complexes (NS1, NP, PA and M1) are phosphoproteins, together with the data obtained using protein kinase inhibitors, it is tempting to speculate that association of the different molecules that constitute the ribonucleoprotein complex might be modulated by a phosphorylation-dephosphorylation mechanism. The relevance of such a hypothetical control mechanism for the regulation of virus replication or gene expression will be a subject for further experimentation.
